- -

A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy

Show full item record

Herance, JR.; García Gómez, H.; Guitierrez Carcedo, P.; Navalón Oltra, S.; Pineda-Lucena, A.; Palomino-Schätzlein, M. (2019). A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy. The Analyst. 144(4):1265-1274. https://doi.org/10.1039/c8an01827h

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/154119

Files in this item

Item Metadata

Title: A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy
Author: Herance, Jose Raul García Gómez, Hermenegildo Guitierrez Carcedo, Patricia Navalón Oltra, Sergio Pineda-Lucena, Antonio Palomino-Schätzlein, M.
UPV Unit: Universitat Politècnica de València. Departamento de Química - Departament de Química
Issued date:
Abstract:
[EN] Gold nanoparticles have high potential in the biomedical area, especially in disease diagnosis and treatment. The application of these nanoparticles requires the presence of stabilizers to avoid their agglomeration. ...[+]
Subjects: Cells , Cytotoxicity , Perturbations , Proteomics , Reveals , Assay , Ceria
Copyrigths: Reserva de todos los derechos
Source:
The Analyst. (issn: 0003-2654 )
DOI: 10.1039/c8an01827h
Publisher:
The Royal Society of Chemistry
Publisher version: https://doi.org/10.1039/c8an01827h
Project ID:
info:eu-repo/grantAgreement/MINECO//SAF2014-53977-R/ES/HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFIC. DE DIANAS, LA EVAL. DE FARMACOS Y LA PERSONAL. DE TRATAMIENTOS BASADA EN APROX. METABOLOMICAS/
ISCIII/PI16/02064
ISCIII/CP13/00252
MINECO/SAF2017-89229-R
MINECO/RD12/0036/0025
Thanks:
This work was supported by the Carlos III Health Institute, the European Regional Development Fund (PI16/02064 and CP13/00252) and the Spanish Ministerio de Economia y Competitividad (SAF2014-53977-R, SAF2017-89229-R and ...[+]
Type: Artículo

recommendations

 

This item appears in the following Collection(s)

Show full item record